R&D Vision
REANZEN

Driving innovation,
shaping the future of biotech

REANZEN invests in cultivating top talent and securing proprietary core technologies. Through rigorous quality standards and relentless material innovation, we build global competitiveness and deliver world-class biotech solutions.

From biomaterial discovery to post-market surveillance: 5-Phase Research Pipeline

All phases of filler & skin booster medical device development are carried out step by step in accordance with international standards (ISO 10993 · GLP · GCP · ISO 13485) and country-specific regulatory requirements

01

Biomaterial Discovery

  • Analyze mechanisms for skin improvement, define target indications, and select candidate materials
  • Establish molecular weight, purity, and impurity specifications to verify suitability as medical-grade raw materials
02

Formulation & Process

  • Design products for procedural goals and optimize rheological properties such as viscoelasticity, cohesivity, and extrusion force
  • Verify the initial safety and efficacy of completed prototypes through evaluation
03

Non-clinical Validation

  • Evaluate biological safety in accordance with the ISO 10993 international standard
  • Confirm tissue responses in animal models to demonstrate safety and efficacy before human application
04

Pivotal Clinical Investigation

  • Design multicenter, randomized, evaluator-blind, controlled trials and obtain regulatory approval of the clinical trial plan
  • Confirm efficacy with validated measures and verify safety by collecting adverse events through follow-up
05

Regulatory & Commercialization

  • Obtain country-specific product approvals with accumulated technical documentation and clinical data
  • Validate mass-production processes under the ISO 13485 quality system and feed post-market safety data back into next-generation product development

Feedback Loop | Post-market clinical & safety data → fed back into next-generation biomaterial discovery

Strategic Market Intelligence

Strategic Market Intelligence

  • Deriving next-generation beauty solutions through global aesthetic trend analysis
  • Analyzing big data from the global cosmetic surgery market to establish initial product specifications and development roadmaps
Advanced Bio-Material Engineering

Advanced Bio-Material Engineering

  • Securing proprietary technologies in biodegradable polymers and bioactive ingredients
  • Building an independent core technology platform spanning material development and formulation expertise
Pre-clinical Bio-Safety Verification

Pre-clinical Bio-Safety Verification

  • Biocompatibility and safety evaluations based on international standards
  • Assessing cytotoxicity, acute/chronic toxicity, genotoxicity and more per medical device biological safety criteria, proactively eliminating all immunological risk factors
Clinical Evidence & Protocol Development

Clinical Evidence & Protocol Development

  • Multicenter clinical trials and optimal procedure guideline development to ensure safety and efficacy
  • Conducting large-scale trials with leading medical institutions and establishing standard protocols that practitioners can apply immediately in the field
Global Regulatory Compliance

Global Regulatory Compliance

  • Obtaining country-specific regulatory approvals (RA) and adhering to global quality standards
  • Strategically navigating the approval processes essential for global market entry and securing export competitiveness through globally recognized quality management system certifications

Reanzen Product Inquiry.

Explore Reanzen's full product lineup